Supplementary
. PALB2 mutation carriers show an increase in the DNA synthesis rate and a decrease in S phase cells, when compared to controls. a, Example of the flow cytometric measurement of DNA synthesis rate and S phase cell population. S phase cells were identified after pulse labeling of the cells with EdU and coupling of the EdUMP incorporated with Alexafluor 594 using click chemistry. S phase cells were identified in the AF594 A -DNA405 A dot plot and the mode of the AF594 A signal of the S phase cells were taken as a measure of the DNA synthesis rate. Measurements were done under normal growth conditions, without any toxic treatments. b, EdU incorporation showing the active DNA synthesis rates and the percentage of S phase cells. Lines indicate the average of the respective cohorts. Data represents an initial analysis of carrier cell lines BR-0734, BR-0736, BR-0737 and BR-0760, and control cell lines BR-0778 and BR-0781. An independent determination with a larger set of cell lines is presented in Supplementary Table S2 .
Supplementary Figure S2 . Phosphorylation of ATR in untreated cells. a, Comparable levels of ATR phosphorylated at serine 428 in undisturbed PALB2 c.1592delT mutation carriers and controls, despite the increased levels of total ATR (see Fig. 4 ). b, Apparently lower ATR activation by phosphorylation in carrier compared to controls (no statistically significant difference). The level of pATR was related to the total amount of ATR. The data represent the averages of two independent western blot determinations of the same set of samples. Lines indicate the average of the respective cohorts. Supplementary Figure S5 . Analysis of cell cycle distribution and checkpoint function in lymphoblastoid cell lines. a, The gating and analysis strategy for flow cytometric cell cycle distribution measurements. The cell population was initially gated in a FSC/SSC dot plot and cell duplets were excluded in a DAPI width/DAPI area dot plot, following analysis of the cell cycle distributions by DAPI (DNA content) and EdU incorporation (DNA synthesis) dot plot to identify G0/G1, S and G2/M phase populations. Finally, mitotic cells were identified within the G2/M phase population as phospho-Histone H3 (Ser10) positives. b, Example of a G2/M phase analysis of a PALB2 mutation carrier and a control cell line, and G2 phase cell numbers and M/G2 ratios before (0 h, top) and 24 h after (bottom) 0.5 µM ET treatment, showing that the control cell line has a tighter G2/M checkpoint than the PALB2 mutation carrier, apparent as a smaller G2 to M ratio. c, Summary of the M/G2 ratio analysis before and after 24 h in the presence of 0.5 µM ET. Lines indicate the average of the respective cohorts. Data points indicate the average of two independent experiments during two separate cultivation periods. For an individual experiment, samples for each cell line were collected at the same time, verifying that cell lines were cultivated the same amount. Although some PALB2 mutation carrier lines show signs of a compromized G2/M checkpoint, there is no statistically significant difference in the M/G2 ratio between the two cohorts.
Supplementary Figure S6 . Effects of etoposide treatment on Chk2 phosphorylation and DNA replication. a, Western blot analyses of Chk2 phosphorylation time course 0-7 h after ET treatment for one representative PALB2 mutation carrier and control line, respectively. The predicted size for Chk2/pChk2 is 62 kDa, and levels were normalized against β-actin (42 kDa). b, Quantitative fiber assay analysis of 1 st pulse origins and c, of 2 nd pulse origins in untreated carriers and controls after ET treatment. White bars represent untreated mutation carriers and controls. Black and grey bars represent carriers and controls, respectively, after ET treatment. All values presented in panel b and c represent the average of two independent determinations. The error bars indicate standard deviations. Lines in the dot plots indicate the median of the respective cohorts. 

